Anikin I A, Bokuchava T A
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech, Saint-Petersburg, Russia, 190013.
P.A. Bayandin Murmansk Regional Clinical Hospital, Murmansk, Russia, 183037.
Vestn Otorinolaringol. 2018;83(3):11-15. doi: 10.17116/otorino201883311.
We have undertaken the analysis of the specific clinical manifestations of acquired cholesteatoma of the middle ear in 437 chronic patients suffering from this pathology. 96.1% of them presented with primarily acquired cholesteatoma of the middle ear (including 53.3% having attic cholesteatoma, 22.8% with sinus cholesteatoma, and 19.9% of tensa retraction cholesteatoma). 3.9% of the patients exhibited a different mechanism of development of cholesteatoma. The secondary acquired mesotympanic cholesteatoma formed in association with the long-term chronic inflammation of the middle ear, concomitant perforation of the tympanic membrane and epithelial invasion from the edge of the tympanic membrane perforation and middle ear cavity. Typmanosclerosis of different degree and localization played an important role in the enhancement of the prevalence of this condition. All types of acquired cholesteatoma were found to extend beyond the point of origin of the disorder. The maximum destruction of the ossicular chain was documented in the patients presenting with sinus cholesteatoma. Those with secondary acquired cholesteatoma showed the worst functional capacity as a result of rigid fixation of the auditory ossicles. The overall cholesteatoma relapse rate (including both residual and recurrent cholesteatoma) was estimated to be 15.6%. It is concluded that the surgical strategy should be chosen on an individual basis for each concrete patient. The long-term observation of the treated patients with the application of the up-to-date radiological techniques is believed to be the indispensable prerequisite for the successful management of the complicated pathology under consideration.
我们对437例患有中耳后天性胆脂瘤的慢性患者的具体临床表现进行了分析。其中96.1%主要表现为中耳后天性胆脂瘤(包括53.3%的上鼓室胆脂瘤、22.8%的鼓窦胆脂瘤和19.9%的鼓膜紧张部内陷胆脂瘤)。3.9%的患者表现出不同的胆脂瘤形成机制。继发性后天性中鼓室胆脂瘤与中耳长期慢性炎症、鼓膜穿孔以及鼓膜穿孔边缘和中耳腔上皮侵入有关。不同程度和部位的鼓室硬化在这种情况患病率的增加中起重要作用。所有类型的后天性胆脂瘤均超出病变起源点。鼓窦胆脂瘤患者的听骨链破坏最为严重。继发性后天性胆脂瘤患者由于听小骨的僵硬固定,功能最差。胆脂瘤的总体复发率(包括残余和复发性胆脂瘤)估计为15.6%。结论是,应针对每个具体患者个体化选择手术策略。应用最新放射技术对接受治疗的患者进行长期观察被认为是成功处理所考虑的复杂病变必不可少的前提条件。